Tags

Type your tag names separated by a space and hit enter

ESWL monotherapy for large stones and staghorn calculi.
Urol Int. 1990; 45(2):95-8.UI

Abstract

From December 1986 through March 1988, 52 renal units (RU) with large stone burden have been treated by ESWL monotherapy. In all patients a ureteral stent was placed prior to lithotripsy, to provide drainage of the kidney during the period of stone passage. Data of 43 RU were collected for the present report. Complications ; following treatment were infrequent (2%), whereas auxiliary measures became necessary in 32% of the patients. After a mean follow-up of 9.1 months, 54% of the patients were found stone-free. Stratification according to different stone types and compositions revealed that none of the 7 patients with complete staghorns could be completely cleared and that struvite stones had a significantly better outcome than calcium oxalate stones (75 vs. 25%). Consequently, for a large but not excessive stone burden in a normal or only slightly dilated renal collecting system, ESWL monotherapy under the protection of a ureteral stent may be a comparably safe alternative to percutaneous surgery.

Authors+Show Affiliations

Division of Urology, University of Ulm, FRG.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

2330665

Citation

Miller, K, et al. "ESWL Monotherapy for Large Stones and Staghorn Calculi." Urologia Internationalis, vol. 45, no. 2, 1990, pp. 95-8.
Miller K, Bachor R, Sauter T, et al. ESWL monotherapy for large stones and staghorn calculi. Urol Int. 1990;45(2):95-8.
Miller, K., Bachor, R., Sauter, T., & Hautmann, R. (1990). ESWL monotherapy for large stones and staghorn calculi. Urologia Internationalis, 45(2), 95-8.
Miller K, et al. ESWL Monotherapy for Large Stones and Staghorn Calculi. Urol Int. 1990;45(2):95-8. PubMed PMID: 2330665.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - ESWL monotherapy for large stones and staghorn calculi. AU - Miller,K, AU - Bachor,R, AU - Sauter,T, AU - Hautmann,R, PY - 1990/1/1/pubmed PY - 1990/1/1/medline PY - 1990/1/1/entrez SP - 95 EP - 8 JF - Urologia internationalis JO - Urol Int VL - 45 IS - 2 N2 - From December 1986 through March 1988, 52 renal units (RU) with large stone burden have been treated by ESWL monotherapy. In all patients a ureteral stent was placed prior to lithotripsy, to provide drainage of the kidney during the period of stone passage. Data of 43 RU were collected for the present report. Complications ; following treatment were infrequent (2%), whereas auxiliary measures became necessary in 32% of the patients. After a mean follow-up of 9.1 months, 54% of the patients were found stone-free. Stratification according to different stone types and compositions revealed that none of the 7 patients with complete staghorns could be completely cleared and that struvite stones had a significantly better outcome than calcium oxalate stones (75 vs. 25%). Consequently, for a large but not excessive stone burden in a normal or only slightly dilated renal collecting system, ESWL monotherapy under the protection of a ureteral stent may be a comparably safe alternative to percutaneous surgery. SN - 0042-1138 UR - https://www.unboundmedicine.com/medline/citation/2330665/ESWL_monotherapy_for_large_stones_and_staghorn_calculi_ L2 - https://www.karger.com?DOI=10.1159/000281678 DB - PRIME DP - Unbound Medicine ER -